Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy.
暂无分享,去创建一个
Jarno Salonen | Jin Fan | Hélder A Santos | Jouni Hirvonen | Dongfei Liu | Ermei Mäkilä | Bárbara Herranz-Blanco | H. Santos | Hongbo Zhang | Jin Fan | J. Salonen | E. Mäkilä | B. Herranz-Blanco | J. Hirvonen | Hongbo Zhang | Dongfei Liu | Chang-Fang Wang | A. Ribeiro | António J Ribeiro | Chang-Fang Wang | Ricardo Rosa | R. Rosa | B. Herranz‐Blanco
[1] H. Santos,et al. Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles. , 2013, ACS nano.
[2] B. Cohen,et al. Rapid cytosolic delivery of luminescent nanocrystals in live cells with endosome-disrupting polymer colloids. , 2010, Nano letters.
[3] D. Weitz,et al. Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. , 2014, Lab on a chip.
[4] J. Baek,et al. Nanocomposites Derived from Polymers and Inorganic Nanoparticles , 2010, Materials.
[5] R. K. Shah,et al. Monodisperse Thermoresponsive Microgels with Tunable Volume‐Phase Transition Kinetics , 2007 .
[6] Hélder A Santos,et al. Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. , 2014, Biomaterials.
[7] H. Santos,et al. Amine modification of thermally carbonized porous silicon with silane coupling chemistry. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[8] Joel A. Cohen,et al. Mannosylated dextran nanoparticles: a pH-sensitive system engineered for immunomodulation through mannose targeting. , 2011, Bioconjugate chemistry.
[9] Guojie Wang,et al. Drug delivery systems for differential release in combination therapy , 2011, Expert opinion on drug delivery.
[10] Robert Langer,et al. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. , 2012, Nano letters.
[11] Robert Langer,et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy , 2010, Proceedings of the National Academy of Sciences.
[12] Kyle E Broaders,et al. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. , 2008, Journal of the American Chemical Society.
[13] Jarno Salonen,et al. Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release , 2013 .
[14] Vesa-Pekka Lehto,et al. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery. , 2014, Small.
[15] Wyatt N Vreeland,et al. Microfluidic mixing and the formation of nanoscale lipid vesicles. , 2010, ACS nano.
[16] G. W. Pratt,et al. Modular ‘Click‐in‐Emulsion’ Bone‐Targeted Nanogels , 2012, Advanced materials.
[17] H. Gu,et al. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells , 2012, International journal of nanomedicine.
[18] C Jeffrey Brinker,et al. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.
[19] H. Santos,et al. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles. , 2011, Biomaterials.
[20] L. Canham,et al. Derivatized Mesoporous Silicon with Dramatically Improved Stability in Simulated Human Blood Plasma , 1999 .
[21] Peter York,et al. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. , 2009, International journal of pharmaceutics.
[22] Joel A. Cohen,et al. Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy , 2009, Proceedings of the National Academy of Sciences.
[23] Michael J Sailor,et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.
[24] Jarno Salonen,et al. Fabrication of a Multifunctional Nano‐in‐micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix , 2014, Advanced materials.
[25] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[26] H. Santos,et al. Multifunctional porous silicon for therapeutic drug delivery and imaging. , 2011, Current drug discovery technologies.
[27] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[28] G. Whitesides. The origins and the future of microfluidics , 2006, Nature.
[29] Nicolas H Voelcker,et al. The biocompatibility of porous silicon in tissues of the eye. , 2009, Biomaterials.
[30] Samuel Zalipsky,et al. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. , 2004, Advanced drug delivery reviews.
[31] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[32] Vesa-Pekka Lehto,et al. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.
[33] Patrick V. Almeida,et al. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. , 2013, Biomaterials.
[34] Joel A. Cohen,et al. Chemoselective ligation in the functionalization of polysaccharide-based particles. , 2009, Journal of the American Chemical Society.
[35] F. Kratz,et al. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[36] Lena Mäler. Solution NMR studies of cell-penetrating peptides in model membrane systems. , 2013, Advanced drug delivery reviews.
[37] Robert Langer,et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.
[38] Robert K Prud'homme,et al. Mechanism for rapid self-assembly of block copolymer nanoparticles. , 2003, Physical review letters.
[39] Robert Langer,et al. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. , 2013, ACS nano.
[40] Niklas Sandler,et al. Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery. , 2013, ACS applied materials & interfaces.
[41] Hélder A Santos,et al. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.
[42] Robert Langer,et al. Microfluidic technologies for accelerating the clinical translation of nanoparticles. , 2012, Nature nanotechnology.
[43] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[44] H. Santos,et al. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.
[45] Joel A. Cohen,et al. Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic Cells , 2010, Advanced materials.
[46] Vesa-Pekka Lehto,et al. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[47] Robert Langer,et al. Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. , 2012, Nanomedicine.
[48] Yifan Jiang,et al. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. , 2013, Advanced drug delivery reviews.
[49] A. Palmer,et al. Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation. , 2012, Journal of the American Chemical Society.
[50] H. Santos,et al. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications. , 2014, Nanomedicine.
[51] Robert Langer,et al. Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics. , 2013, ACS nano.
[52] M. Morris,et al. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.
[53] P. Musto,et al. Compatibilizing polyimide/silica hybrids by alkoxisilane-terminated oligoimides: Morphology–Properties relationships , 2011 .